19 reports of this reaction
1.5% of all HYDROQUINONE reports
#19 most reported adverse reaction
INSOMNIA is the #19 most commonly reported adverse reaction for HYDROQUINONE, manufactured by Obagi Cosmeceuticals LLC. There are 19 FDA adverse event reports linking HYDROQUINONE to INSOMNIA. This represents approximately 1.5% of all 1,310 adverse event reports for this drug.
Patients taking HYDROQUINONE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INSOMNIA is a less commonly reported adverse event for HYDROQUINONE, but still significant enough to appear in the safety profile.
In addition to insomnia, the following adverse reactions have been reported for HYDROQUINONE:
The following drugs have also been linked to insomnia in FDA adverse event reports:
INSOMNIA has been reported as an adverse event in 19 FDA reports for HYDROQUINONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INSOMNIA accounts for approximately 1.5% of all adverse event reports for HYDROQUINONE, making it a notable side effect.
If you experience insomnia while taking HYDROQUINONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.